表紙
市場調查報告書
商品編碼
1029342

心臟再同步化治療(CRT)的全球市場:產業趨勢,佔有率,規模,成長,機會,預測(2021年∼2026年)

Cardiac Resynchronization Therapy (CRT) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 142 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球心臟再同步化治療(CRT)的市場規模,從2015年到2020年顯示緩慢成長,預計從2021年到2026年以約5%的年複合成長率成長。全球心血管疾病增加,是促進市場成長的主要原因之一。再加上心律不整,先天性心臟病,容易患心房纖維顫動等疾病的老年人增加,也推動市場成長。預計個人的醫療費用支出增加,尤其是新興國家的醫療基礎設施的改善等要素,更加推動市場。

本報告提供全球心臟再同步化治療(CRT)市場的相關調查,市場成果,COVID-19的影響,各類型、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球心臟再同步化治療(CRT)市場

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 各類型的市場區隔

  • CRT-心臟去顫器
  • CRT-心律調節器

第7章 各用途的市場區隔

  • 心室內同步不全
  • 心室間(V-V)同步不全
  • 房室間(A-V)同步不全

第8章 各終端用戶的市場區隔

  • 醫院
  • 心臟中心
  • 門診病人手術中心
  • 其他

第9章 各地區的市場區隔

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 各國市場區隔

第10章 SWOT分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 價格分析

第14章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Abbott Laboratories
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • LivaNova Plc
    • Medico S.p.A.
    • Medtronic Plc
    • Merit Medical Systems Inc.
    • MicroPort Scientific Corporation
目錄
Product Code: SR1020F292_Report

The global cardiac resynchronization therapy (CRT) market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Cardiac resynchronization therapy (CRT), or biventricular pacing, refers to a therapeutic procedure to correct or facilitate synchronized beating of the right and left ventricle of the heart. This therapy aids in improving the functioning of the heart, increasing the blood flow and facilitating faster recovery of the patient. It involves the use of a defibrillator to generate a pulse and thin insulated wires or leads to send electric impulses into the lower chambers of the heart. The device is surgically implanted and is connected to an external computer for periodic monitoring of the heart. It sends small electrical impulses to the left and right ventricles to support contraction at the same time.

The increasing prevalence of cardiovascular diseases (CVDs) across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to ailments such as arrhythmias, congenital heart disease and atrial fibrillation, is providing a thrust to the market growth. In line with this, increasing health consciousness and awareness regarding the available treatment alternatives for heart-related ailments is also contributing to the market growth. Various technological advancements, such as the development of MRI-safe and wireless CRT devices, are acting as other growth-inducing factors. These novel systems aid in optimizing CRT programming and multipoint pacing to promote the healthy activity of the heart. Other factors, including increasing healthcare expenditures capacities of the individuals, along with improvements in the healthcare infrastructure, especially in the developing nations, are anticipated to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac resynchronization therapy (crt) market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type, application and end user.

Breakup by Type:

  • CRT-Defibrillator
  • CRT-Pacemaker

Breakup by Application:

  • Intraventricular Dyssynchrony
  • Interventricular (V-V) Dyssynchrony
  • Atrioventricular (A-V) Dyssynchrony

Breakup by End User:

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgery Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova Plc, Medico S.p.A., Medtronic Plc, Merit Medical Systems Inc. and MicroPort Scientific Corporation. Key Questions Answered in This Report:

  • How has the global cardiac resynchronization therapy (CRT) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cardiac resynchronization therapy (CRT) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cardiac resynchronization therapy (CRT) market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Resynchronization Therapy (CRT) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 CRT-Defibrillator
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CRT-Pacemaker
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Intraventricular Dyssynchrony
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Interventricular (V-V) Dyssynchrony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Atrioventricular (A-V) Dyssynchrony
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Biotronik SE & Co. KG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 LivaNova Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Medico S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Merit Medical Systems Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 MicroPort Scientific Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiac Resynchronization Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Resynchronization Therapy Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Cardiac Resynchronization Therapy Market: Breakup by Type (in %), 2020
  • Figure 4: Global: Cardiac Resynchronization Therapy Market: Breakup by Application (in %), 2020
  • Figure 5: Global: Cardiac Resynchronization Therapy Market: Breakup by End User (in %), 2020
  • Figure 6: Global: Cardiac Resynchronization Therapy Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 9: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 10: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Cardiac Resynchronization Therapy (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Cardiac Resynchronization Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Cardiac Resynchronization Therapy (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Cardiac Resynchronization Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: North America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: North America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: United States: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: United States: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Canada: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Canada: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Asia Pacific: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Asia Pacific: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: China: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: China: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Japan: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Japan: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: India: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: India: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: South Korea: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: South Korea: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Australia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Australia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Indonesia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Indonesia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Europe: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Europe: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Germany: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Germany: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: France: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: France: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: United Kingdom: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: United Kingdom: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Italy: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Italy: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Spain: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Spain: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Russia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Russia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Latin America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Latin America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Brazil: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Brazil: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Mexico: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Mexico: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Middle East and Africa: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Middle East and Africa: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Global: Cardiac Resynchronization Therapy (CRT) Industry: SWOT Analysis
  • Figure 75: Global: Cardiac Resynchronization Therapy (CRT) Industry: Value Chain Analysis
  • Figure 76: Global: Cardiac Resynchronization Therapy (CRT) Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Resynchronization Therapy Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Type (in Million US$), 2021-2026
  • Table 3: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 4: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by End User (in Million US$), 2021-2026
  • Table 5: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Cardiac Resynchronization Therapy Market Structure
  • Table 7: Global: Cardiac Resynchronization Therapy Market: Key Players